Clinical studies recruiting near Chesterfield

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH)
Phase 3 · St. Luke's Hospital, Sleep Medicine and Research Center · Harmony Biosciences Management, Inc. · NCT07500090 Safety and Efficacy of EXV-802 and EXV-801 in the Treatment of Agitation in Alzheimer's Disease Dementia
Phase 2/Phase 3 · Galen Research LLC · Exciva GmbH · NCT07284472 A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel
Phase 3 · St. Luke's Hospital - Chesterfield /ID# 251688 · AbbVie · NCT04928846 BioPoly® Partial Resurfacing Knee Implant IDE
NA · Washington University Orthopedics · BioPoly LLC · NCT06915363 Long-Term Real-World Outcomes Study on Patients Implanted With a Neurostimulator
Phase N/A · Saint Louis Pain Consultants · Abbott Medical Devices · NCT03876054 Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SL
Phase 3 · Saint Luke's Hospital · National Cancer Institute (NCI) · NCT04269902 A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary H
Phase 2/Phase 3 · Diabetes and Endocrinology Specialists /ID# 259068 · AbbVie · NCT06345339 An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Activ
Phase 3 · Gateway Gastroenterology: 8400097 · Sanofi · NCT07184931 An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerabilit
Phase 3 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT07517263 Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
Phase 3 · Saint Luke's Hospital · ECOG-ACRIN Cancer Research Group · NCT04566328 The Early Valve Replacement in Severe ASYmptomatic Aortic Stenosis Study
NA · Chesterfield Royal Hospital · University of Leicester · NCT04204915 Studying Solriamfetol Modulation of TAAR-1, Dopamine, and Norepinephrine in Shift Work Disorder (SUSTAIN)
Phase 3 · Clinical Research Site · Axsome Therapeutics, Inc. · NCT06568367 A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Phase 3 · Clinical Research Professionals · Eli Lilly and Company · NCT07282600 A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson'
Phase 2/Phase 3 · Site-044 · Biohaven Therapeutics Ltd. · NCT06976268 Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The Co
Phase 2 · Saint Luke's Hospital · National Cancer Institute (NCI) · NCT05564377 A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
Phase 3 · Clinical Research Professionals · Eli Lilly and Company · NCT07392190 A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD
Phase 3 · The Lung Research Center · Hoffmann-La Roche · NCT05878769 An Open Label Trial to Evaluate the Efficacy and Safety of PRAX-628 in Adults With Focal Onset or Tonic-Clonic Seizures
Phase 2 · Praxis Research Site · Praxis Precision Medicines · NCT06908356 A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Phase 3 · Saint Luke's Hospital · National Cancer Institute (NCI) · NCT05675410 Extension Study for the Port Delivery System With Ranibizumab (Portal)
Phase 3 · Midwest Vision Research Foundation · Hoffmann-La Roche · NCT03683251 S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic
NA · Saint Luke's Hospital · SWOG Cancer Research Network · NCT03723928 The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis
Phase 3 · The Lung Research Center, LLC · Boehringer Ingelheim · NCT06872892 Randomised Evaluation of Sodium Dialysate Levels on Vascular Events
Phase 4 · Chesterfield Dialysis Unit · University of Sydney · NCT02823821 Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma
Phase 3 · Saint Luke's Hospital · National Cancer Institute (NCI) · NCT06337318 A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary
Phase 2 · Research Site · AstraZeneca · NCT07082738 Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung
Phase 3 · Saint Luke's Hospital · National Cancer Institute (NCI) · NCT04267848 A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Acti
Phase 3 · Gateway Gastroenterology - Site Number: 8400097 · Sanofi · NCT07185009 Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Phase 3 · Saint Luke's Hospital · ECOG-ACRIN Cancer Research Group · NCT03937635 A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Pr
Phase 3 · The Lung Research Center, LLC · Boehringer Ingelheim · NCT06238622 A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Tre
Phase 4 · Midwest Vision Research Foundation · Genentech, Inc. · NCT04853251

Look up another city

Look up another condition